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Tobacco use causes a tremendous amount of morbidity and mortality globally, with a staggering level of financial
costs. In many countries, public health interventions have been able to reduce the prevalence of smoking and the
associated burden. However, despite these successes, there is still much work left to be done. This commentary
argues that the tobacco control interventions recommended by the World Health Organization are necessary but
not sufficient to adequately address the consequences of tobacco use.The campaign against tobacco has been one of the most
successful public health endeavors in modern history.
Much of the success in tobacco control is attributable to
regulations and policies that have addressed public edu-
cation, economic incentives to use tobacco, and protec-
tion of non-smokers. Prevalence rates have fallen by half
in many countries, resulting in potentially hundreds of
millions of lives saved worldwide.
Yet, the magnitude and scope of the tobacco epidemic
remains massive. Smoking causes a level of burden that
would not be acceptable from any other commercial
product. Ginsburg and Geva estimate, conservatively,
that in 2014 alone, nearly 8000 deaths could be attrib-
uted to smoking tobacco in Israel [1]. The good news is
that this estimate is down from close to 11,000 deaths
attributable to tobacco in 2001. Even with ignoring
population growth, the decline in smoking prevalence
has protected 60 people from tobacco use related death
each and every week, in Israel alone. This account does
not even take into consideration the suffering that to-
bacco use causes to many people from chronic diseases,
various infectious diseases and from longer recovery
from certain surgical procedures. Furthermore, the lag
between tobacco exposure and the onset of disease
means that the burden will continue to decrease into the
future, purely based on changes in prevalence that have
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article, unless otherwise stated.Ginsburg and Geva also highlight that the costs associ-
ated with smoking go beyond the price of mortality and
morbidity to include a substantial financial burden. Their
cost estimate is once again a conservative approximation
of the total financial burden, focusing on direct health care
costs. It only roughly estimates the costs due to abstentee-
ism and leaves aside private costs due to smoking breaks,
illness and loss of productivity due to years of productive
life lost. Philip Morris, among others, suggests cynically
that early mortality is a benefit to government coffers [2],
but ignores the substantial death and disability that occurs
among those of working age. It is well known that cigarette
smokers live 10 years less on average [3], but it is less
known that a male nonsmoker has an 81% chance of living
to 70 years old, while a male smoker has only a 55% chance
of making it to that milestone alive.
As Ginsburg and Geva report, globally, it is estimated
that 5 million deaths each year are attributable to smok-
ing, with trends driving a rise to as much as 10 million
deaths per year by the 2030s [4]. In response, the World
Health Organization [WHO] has set out the Framework
Convention for Tobacco Control [FCTC]. The FCTC
and its guidelines provide the foundation for countries
and health regions to implement and manage tobacco
control [5]. To help make this a reality, the MPOWER
package of measures was introduced by WHO in 2008.
The MPOWER Report [6] has defined a set of policies
that are consistent with the FCTC, which includes
Monitor tobacco use and prevention policies, Protect
people from tobacco smoke, Offer help to quit tobacco
use, Warn about the dangers of tobacco, Enforce bans
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each nation imposes taxes on cigarettes that constitute 75%
of the retail price; implements comprehensive smoke-free
indoor air laws and advertising/marketing restrictions;
requires large, bold and graphic health warnings; provides
broad access to cessation treatments; and implements well-
funded tobacco control media campaigns.
David Levy’s SIMSMOKE model has been used to
calculate the expected change in smoking attributable
mortality in Israel, if various interventions are adopted
[7]. This SIMSMOKE model [using the Doll et al. find-
ing that half of long term users are killed by tobacco]
projects that due to policy changes between 2007 and
2010, 35,264 deaths will be averted in the future due to
offering cessation treatments and 80,134 will be averted
due to tax increases.
In Ontario, Canada—our home province– we have
applied the SIMSMOKE model to a jurisdiction with
relatively strong tobacco control policies [8]. We found
that implementation of the full package of MPOWER sug-
gestions to the highest level could reduce current smoking
prevalence from an already low 18% in 2013 to 12% in
2043, and save 50,000 lives over that period. These results
suggest that these well studied and effective interventions
should be implemented immediately for greatest effect.
On the other hand, the results from Ontario are disap-
pointing—despite the implementation of a strong package
of tobacco control policies over a period of thirty years
(and nearly 90 years after the acceptance of the health
risks associated with smoking) optimistic projections find
that more than 1 in 10 people will continue to smoke.
This suggests that much bolder and more effective policies
are needed to bring tobacco use and the burden associated
with tobacco use down to acceptable levels in Canada, in
Israel, and in other jurisdictions around the world. That is,
while the MPOWER package will have a substantial
impact on public health, more comprehensive policies will
be needed to reduce the prevalence of smoking further
and faster.
There are several ‘beyond MPOWER’ policy measures
that are supported by some evidence. Jha and Peto rec-
ommend at least of tripling of the taxes on tobacco to
make a substantial dent in the use of tobacco [9]. Plain
packaging and large graphic warnings could be a strong
policy tools to reduce the number of adolescents starting
smoking [10]. Smoking bans in more public places,
including patios, doorways and parks, could not only de-
crease physical and social exposure to tobacco use, but
also increase cessation and decrease initiation [11]. Ef-
forts to control the rampant availability of tobacco on
every corner may help smokers stay quit, encourage add-
itional quit attempts and decrease initiation [12]. Simi-
larly, product regulations could make smoking less
appealing to novice and experienced smokers.Policy makers will also have to deal with new chal-
lenges like tobacco promotion via social media and the
use of e-cigarettes [13]. There are no guarantees that
tobacco use will continue to decline into the future with-
out close attention to the issue and further action from
those interested in public health. Politicians and health
policy advisors consistently underestimate public prefer-
ence for bold tobacco control action [14]. Now is the
time to start thinking about the endgame for tobacco
and the policies and regulations that will reduce the bur-
den of tobacco to zero. While we have much to celebrate
in terms of the successes in tobacco control, Ginsburg
and Geva remind us of the tremendous burden still
affecting Israel and countries around the world.
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